180 related articles for article (PubMed ID: 22205628)
1. A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor.
Lorenson MY; Ueda EK; Chen KE; Walker AM
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E585-94. PubMed ID: 22205628
[TBL] [Abstract][Full Text] [Related]
2. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V
Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated human prolactin: alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay.
Haro LS; Lee DW; Singh RN; Bee G; Markoff E; Lewis UJ
J Clin Endocrinol Metab; 1990 Aug; 71(2):379-83. PubMed ID: 2380335
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation.
Rycyzyn MA; Reilly SC; O'Malley K; Clevenger CV
Mol Endocrinol; 2000 Aug; 14(8):1175-86. PubMed ID: 10935542
[TBL] [Abstract][Full Text] [Related]
5. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
[TBL] [Abstract][Full Text] [Related]
6. Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide.
Langenheim JF; Chen WY
J Endocrinol; 2009 Dec; 203(3):375-87. PubMed ID: 19770179
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms.
Pellegrini I; Gunz G; Ronin C; Fenouillet E; Peyrat JP; Delori P; Jaquet P
Endocrinology; 1988 Jun; 122(6):2667-74. PubMed ID: 3131120
[TBL] [Abstract][Full Text] [Related]
8. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
9. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
Peterson FC; Brooks CL
Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206
[TBL] [Abstract][Full Text] [Related]
10. A growth hormone/prolactin-binding protein in human milk.
Mercado M; Baumann G
J Clin Endocrinol Metab; 1994 Dec; 79(6):1637-41. PubMed ID: 7989468
[TBL] [Abstract][Full Text] [Related]
11. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
12. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
[TBL] [Abstract][Full Text] [Related]
13. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures.
Ueda EK; Huang K; Nguyen V; Ferreira M; Andre S; Walker AM
Cell Tissue Res; 2011 Nov; 346(2):175-89. PubMed ID: 22081226
[TBL] [Abstract][Full Text] [Related]
14. Both prolactin (PRL) and a molecular mimic of phosphorylated PRL, S179D-PRL, protect the hippocampus of female rats against excitotoxicity.
Morales T; Lorenson M; Walker AM; Ramos E
Neuroscience; 2014 Jan; 258():211-7. PubMed ID: 24252319
[TBL] [Abstract][Full Text] [Related]
15. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and the prolactin receptor: new targets of an old hormone.
Harris J; Stanford PM; Oakes SR; Ormandy CJ
Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
[TBL] [Abstract][Full Text] [Related]
17. [Action mechanism of pituitary hormones--receptor and signal transduction--prolactin].
Aono T; Yokoyama Y
Nihon Rinsho; 1993 Oct; 51(10):2631-5. PubMed ID: 8254931
[TBL] [Abstract][Full Text] [Related]
18. The ontogenesis of human fetal hormones. III. Prolactin.
Aubert MJ; Grumbach MM; Kaplan SL
J Clin Invest; 1975 Jul; 56(1):155-64. PubMed ID: 1141430
[TBL] [Abstract][Full Text] [Related]
19. Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression.
Ferraris J; Boutillon F; Bernadet M; Seilicovich A; Goffin V; Pisera D
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E356-64. PubMed ID: 22094470
[TBL] [Abstract][Full Text] [Related]
20. Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.
Langenheim JF; Chen WY
Breast Cancer Res Treat; 2005 Apr; 90(3):281-93. PubMed ID: 15830142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
